Agile Therapeutics Inc. (AGRX)
NASDAQ: AGRX
· Real-Time Price · USD
1.51
0.05 (3.42%)
At close: Aug 22, 2024, 9:58 PM
Agile Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -15.86M | -7.79M | -14.46M | 8.24M | -10.62M | -19.03M | -25.41M | -67.01M | -64.12M | -69.53M | -74.89M | -69.16M | -67.91M | -61.1M |
Depreciation & Amortization | 403K | 396K | 386K | 377K | 541K | 1.04M | 1.53M | 2.02M | 2.31M | 2.27M | 2.22M | 1.78M | 1.28M | 778K |
Stock-Based Compensation | 1.62M | 1.82M | 1.98M | 1.94M | 2.04M | 2.23M | 2.49M | 2.83M | 3.19M | 3.36M | 3.34M | 3.18M | 2.94M | 2.94M |
Other Working Capital | 4.35M | 5.88M | 1.48M | -3.59M | -6.98M | -8.03M | -7.61M | -8.93M | 6.12M | 30.95M | 35.32M | 33.25M | 20.11M | -2.38M |
Other Non-Cash Items | 612K | 891K | -624K | -26.04M | -14.33M | -14.23M | -12.43M | 13.16M | 19.78M | 19.83M | 19.85M | 19.89M | 1.76M | 1.68M |
Deferred Income Tax | -2.6M | -4.27M | -4.27M | -5.2M | -1.67M | n/a | n/a | 3.91M | -12.86M | -12.86M | -12.86M | -16.77M | n/a | n/a |
Change in Working Capital | 9.16M | 2.71M | 7.42M | 9.37M | -4.33M | 7.2M | -2.13M | -5.91M | -1.18M | -8.34M | -2.85M | -4.85M | -740K | 1.61M |
Operating Cash Flow | -1.71M | -10.46M | -9.58M | -11.31M | -28.38M | -22.79M | -35.95M | -51.01M | -52.88M | -65.28M | -65.2M | -65.93M | -62.67M | -54.09M |
Capital Expenditures | n/a | n/a | n/a | -7K | -133K | -140K | -266K | -314K | -253K | -324K | -269K | -271K | -280K | -260K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.13M | -2.13M | -2.13M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.92M | -7.01M | -7.01M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -39.73M | -34.73M | -16.26M | n/a | 49.23M | 44.23M | 25.76M |
Other Investing Acitivies | n/a | n/a | n/a | -133K | -133K | -133K | -259K | 39.6M | 44.6M | 63.08M | 79.46M | 41.86M | 41.86M | -24.43M |
Investing Cash Flow | n/a | n/a | n/a | -7K | -133K | -140K | -266K | -314K | 4.75M | 23.15M | 39.46M | 47.04M | 41.93M | -24.34M |
Debt Repayment | -2.68M | -2.96M | -1.35M | -1.08M | -12.89M | -12.6M | -17.38M | -17.15M | -5M | -5M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2.13M | 4.38M | n/a | n/a | 6.51M | n/a | n/a | n/a | n/a | n/a | 75K | 190K | 400K | 566K |
Financial Cash Flow | 1.77M | 8.64M | 6.89M | 8.04M | 18.13M | 23.48M | 22.18M | 42.6M | 35.05M | 29.41M | 30.42M | 9.46M | 7.4M | 975K |
Net Cash Flow | 64K | -1.81M | -2.69M | -3.27M | -10.24M | 686K | -13.9M | -8.59M | -13.09M | -12.72M | 4.68M | -9.43M | -13.33M | -77.46M |
Free Cash Flow | -1.71M | -10.46M | -9.58M | -11.31M | -28.51M | -22.93M | -36.21M | -51.32M | -53.14M | -65.61M | -65.47M | -66.2M | -62.95M | -54.35M |